Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RV-P1501 in Peripheral Artery Occlusive Disease
NCT03214887Phase 2Withdrawn
- Sponsor
- Academia Sinica
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of RV-P1501 in peripheral arterial occlusive disease (PAOD), critical limb ischemia (CLI), sponsored by Academia Sinica. Planned start Jan 2017; status: withdrawn.
02
Drugs
RV-P1501
03
Conditions
peripheral arterial occlusive disease (PAOD)critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT03214887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03214887.